Skip to main content
. 2021 Aug 30;11:733595. doi: 10.3389/fonc.2021.733595

Figure 2.

Figure 2

Construction of the prognostic model and nomogram. (A) “Leave-one-out” cross-validation for parameter selection during LASSO regression; (B) survival curves of patients in the high-risk and low-risk groups; (C) heatmap of lncRNAs in the model; (D) curve of the risk score; (E) distribution of survival status; (F) co-expression relationship between glycolytic genes and lncRNAs in the model; (G) nomogram for survival prediction.